| Literature DB >> 30356640 |
Eliane Aparecida Castro1,2, Ana Belén Peinado1,2, Pedro Jose Benito1,2, Mercedes Galindo3, Marcela González-Gross1,4, Rocío Cupeiro1,2.
Abstract
BACKGROUND: Increased peak oxygen consumption (VO2peak) can reduce cardiovascular risks associated with obesity. Our aim was to analyze the effect of a weight loss program on cardiovascular fitness in overweight (W) and obese (O) subjects.Entities:
Keywords: Combined training; Endurance training; Obesity; Oxygen consumption; Physical activity; Strength training; Ventilatory threshold
Year: 2016 PMID: 30356640 PMCID: PMC6189257 DOI: 10.1016/j.jshs.2016.04.007
Source DB: PubMed Journal: J Sport Health Sci ISSN: 2213-2961 Impact factor: 7.179
Fig. 1Timeline of the study. E = endurance training group; HHR = heart rate reserve; PA = physical activity recommendations group; RM = repetitions maximum; S = strength training group; SE = combined strength and endurance training group.
Characteristics at baseline (mean ± SD).
| Variable | Male | Female | ||
|---|---|---|---|---|
| Overweight | Obese | Overweight | Obese | |
| Age (year) | 36.3 ± 8.0 | 38.6 ± 7.5 | 33.3 ± 8.5 | 38.4 ± 7.7 |
| Body weight (kg) | 87.5 ± 6.9 | 101.2 ± 7.9 | 73.5 ± 5.8 | 86.3 ± 8.5 |
| Height (cm) | 175.3 ± 6.4 | 176.7 ± 5.9 | 162.0 ± 6.1 | 163.0 ± 7.0 |
| Body mass index (kg/m2) | 28.4 ± 1.1 | 32.4 ± 1.9 | 28.0 ± 1.3 | 32.4 ± 1.9 |
| Percentage fat (%) | 33.7 ± 4.6 | 38.2 ± 4.0 | 43.3 ± 3.7 | 47.1 ± 3.6 |
| Lean body mass (kg) | 55.7 ± 5.5 | 59.8 ± 5.0 | 40.3 ± 4.2 | 44.1 ± 4.7 |
| Fat mass (kg) | 28.5 ± 5.2 | 37.2 ± 5.8 | 30.7 ± 3.7 | 39.5 ± 6.5 |
| VO2peak (L/min) | 3.2 ± 0.6 | 3.6 ± 0.6 | 2.0 ± 0.3 | 2.5 ± 0.4 |
| VO2peak (mL/kg/min) | 36.5 ± 1.1 | 36.1 ± 0.8 | 27.7 ± 0.5 | 28.2 ± 0.5 |
p < 0.05, **p < 0.001, compared with overweight.
Peak oxygen consumption before and after weight loss intervention (mean ± SD).
| Male | Female | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Overweight | Obese | Observed power | Overweight | Obese | Observed power | |||||
| Baseline | 3.2 ± 0.6 | 3.6 ± 0.6 | >0.99 | 0.38 | 2.0 ± 0.3 | 2.5 ± 0.4 | 0.96 | 0.15 | ||
| Post-intervention | 3.7 ± 0.5 | 3.8 ± 0.6 | 2.3 ± 0.4 | 2.5 ± 0.4 | ||||||
| Δ | 0.5 ± 0.4 | 0.2 ± 0.5 | 0.3 ± 0.3 | −0.1 ± 0.3 | ||||||
| Baseline | 37.4 ± 6.2 | 36.0 ± 5.9 | >0.99 | 0.65 | 27.7 ± 3.8 | 28.2 ± 3.3 | >0.99 | 0.55 | ||
| Post-intervention | 46.6 ± 5.6 | 41.4 ± 6.9 | 33.8 ± 5.6 | 31.0 ± 4.6 | ||||||
| Δ | 9.2 ± 5.7 | 5.4 ± 5.6 | 6.1 ± 4.4 | 2.8 ± 4.2 | ||||||
| Baseline | 57.9 ± 8.3 | 60.5 ± 8.1 | >0.99 | 0.41 | 50.7 ± 6.2 | 55.8 ± 6.1 | >0.99 | 0.22 | ||
| Post-intervention | 67.3 ± 6.7 | 63.9 ± 7.7 | 57.0 ± 8.4 | 56.5 ± 7.7 | ||||||
| Δ | 9.4 ± 8.1 | 3.4 ± 8.3 | 6.3 ± 6.5 | 0.7 ± 7.3 | ||||||
Note: Data in bold for the p value indicate significant difference.
Abbreviations: BMI = body mass index classification; G = intervention group; T = time; VO2peak = peak oxygen consumption.
p < 0.05, **p < 0.001, compared with baseline.
p < 0.05, compared with overweight.
VO2peak classified as fit and at baseline and post-intervention (%).
| Male | Female | |||
|---|---|---|---|---|
| PA | SUP | PA | SUP | |
| Baseline | 6.0 | 13.0 | 5.3 | 1.4 |
| Post-intervention | 44.0 | 56.0 | 21.1 | 31.0 |
| Δ | 38.0 | 43.0 | 15.8 | 29.6 |
Abbreviations: PA = physical activity group; SUP = supervised training group.
Oxygen consumption in VT1 and VT2 before and after weight loss intervention (mean ± SD).
| Overweight | Obese | Observed power | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | E | SE | PA | S | E | SE | PA | ||||
| >0.99 | 0.54 | ||||||||||
| Baseline | 1.2 ± 0.2 | 1.2 ± 0.1 | 1.5 ± 0.4 | 1.3 ± 0.2 | 1.6 ± 0.2 | 1.5 ± 0.2 | 1.6 ± 0.3 | 1.6 ± 0.2 | |||
| Post-intervention | 1.7 ± 0.2 | 1.6 ± 0.4 | 1.7 ± 0.3 | 1.9 ± 0.4 | 1.7 ± 0.3 | 1.8 ± 0.3 | 2.1 ± 0.2 | 1.8 ± 0.4 | |||
| Δ | 0.5 ± 0.2 | 0.4 ± 0.4 | 0.2 ± 0.3 | 0.6 ± 0.3 | 0.1 ± 0.1- | 0.3 ± 0.3 | 0.5 ± 0.3 | 0.3 ± 0.4 | |||
| >0.99 | 0.25 | ||||||||||
| Baseline | 38.9 ± 3.1 | 37.9 ± 2.9 | 44.9 ± 2.2 | 42.6 ± 3.2 | 42.8 ± 2.1 | 46.1 ± 2.4 | 42.6 ± 2.3 | 43.7 ± 2.2 | |||
| Post-intervention | 46.1 ± 2.9 | 45.3 ± 2.7 | 44.1 ± 2.0 | 52.3 ± 2.9 | 45.9 ± 2.0 | 51.0 ± 2.2 | 50.9 ± 2.1 | 50.4 ± 2.1 | |||
| Δ | 7.2 ± 4.2 | 7.4 ± 3.9 | −0.8 ± 3.0 | 9.7 ± 4.3 | 3.1 ± 2.9 | 4.9 ± 3.3 | 8.3 ± 3.1 | 6.7 ± 3.0 | |||
| >0.99 | 0.33 | ||||||||||
| Baseline | 2.6 ± 0.7 | 2.7 ± 0.3 | 2.6 ± 0.5 | 2.6 ± 0.6 | 3.2 ± 0.7 | 2.6 ± 0.4 | 2.9 ± 0.5 | 2.9 ± 0.5 | |||
| Post-intervention | 3.3 ± 0.6 | 3.0 ± 0.5 | 3.2 ± 0.9 | 2.9 ± 0.7 | 3.1 ± 0.6 | 3.0 ± 0.4 | 3.5 ± 0.6 | 3.2 ± 0.5 | |||
| Δ | 0.8 ± 0.3 | 0.3 ± 0.5 | 0.6 ± 1.0 | 0.3 ± 0.2 | −0.2 ± 0.3 | 0.4 ± 0.3 | 0.6 ± 0.6 | 0.2 ± 0.4 | |||
| T = 0.149 | 0.30 | 0.03 | |||||||||
| Baseline | 80.4 ± 4.0 | 84.6 ± 3.7 | 80.5 ± 2.8 | 83.5 ± 4.1 | 82.5 ± 2.7 | 79.0 ± 3.1 | 79.4 ± 3.0 | 81.8 ± 2.8 | |||
| Post-intervention | 86.2 ± 5.7 | 84.0 ± 5.3 | 85.0 ± 4.0 | 79.7 ± 5.8 | 83.1 ± 3.9 | 85.9 ± 4.4 | 84.6 ± 4.2 | 87.6 ± 4.0 | |||
| Δ | 5.8 ± 7.2 | −0.6 ± 6.7 | 4.5 ± 5.1 | −3.7 ± 7.3 | 0.6 ± 4.9 | 6.9 ± 5.6 | 5.2 ± 5.3 | 5.8 ± 5.1 | |||
| >0.99 | 0.30 | ||||||||||
| Baseline | 1.0 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.1 | 1.4 ± 0.2 | 1.2 ± 0.2 | 1.3 ± 0.2 | 1.2 ± 0.3 | |||
| Post-intervention | 1.1 ± 0.3 | 1.4 ± 0.3 | 1.2 ± 0.4 | 1.2 ± 0.2 | 1.3 ± 0.3 | 1.3 ± 0.3 | 1.4 ± 0.2 | 1.2 ± 0.2 | |||
| Δ | 1 | 0.5 ± 0.3 | 0.3 ± 0.3 | 0.2 ± 0.1 | −0.1 ± 0.1 | 0.1 ± 0.3 | 0.2 ± 0.3 | 0.1 ± 0.2 | |||
| 0.98 | 0.17 | ||||||||||
| Baseline | 48.0 ± 2.2 | 43.5 ± 2.0 | 43.8 ± 2.5 | 46.7 ± 2.3 | 54.8 ± 2.2 | 49.9 ± 2.0 | 48.8 ± 2.2 | 53.7 ± 2.5 | |||
| Post-intervention | 49.2 ± 2.6 | 60.0 ± 2.4 | 50.0 ± 2.9 | 52.7 ± 2.8 | 51.0 ± 2.6 | 53.9 ± 2.3 | 54.5 ± 2.6 | 55.3 ± 2.9 | |||
| Δ | 1.2 ± 3.2 | 16.5 ± 2.8 | 6.2 ± 3.5 | 6.0 ± 3.3 | −3.8 ± 3.2 | 4.0 ± 2.8 | 5.7 ± 3.2 | 1.6 ± 3.5 | |||
| 0.84 | 0.10 | ||||||||||
| Baseline | 1.7 ± 0.3 | 1.6 ± 0.2 | 1.5 ± 0.2 | 1.7 ± 0.3 | 2.1 ± 0.3 | 2.1 ± 0.4 | 2.1 ± 0.3 | 1.8 ± 0.2 | |||
| Post-intervention | 1.7 ± 0.4 | 2.0 ± 0.3 | 1.8 ± 0.6 | 1.7 ± 0.3 | 2.1 ± 0.4 | 2.1 ± 0.4 | 2.2 ± 0.3 | 2.0 ± 0.3 | |||
| Δ | 0.0 ± 0.3 | 0.3 ± 0.3 | 0.2 ± 0.4 | 0.1 ± 0.4 | −0.0 ± 0.3 | −0.0 ± 0.5 | 0.1 ± 0.3 | 0.1 ± 0.1 | |||
| T = 0.836 | 0.05 | <0.01 | |||||||||
| Baseline | 82.5 ± 2.2 | 82.3 ± 2.0 | 77.2 ± 2.5 | 82.5 ± 2.3 | 83.7 ± 2.2 | 85.9 ± 2.0 | 80.7 ± 2.2 | 83.3 ± 2.5 | |||
| Post-intervention | 80.6 ± 2.9 | 84.6 ± 2.6 | 76.2 ± 3.2 | 78.1 ± 3.1 | 85.2 ± 2.9 | 84.8 ± 2.6 | 84.4 ± 2.9 | 86.7 ± 3.2 | |||
| Δ | −1.9 ± 3.8 | 2.3 ± 3.4 | −1.0 ± 4.2 | −4.4 ± 4.0 | 1.5 ± 3.8 | −1.1 ± 3.4 | 3.7 ± 3.8 | 3.4 ± 4.2 | |||
Note: Data in bold for the p value indicate significant difference.
Abbreviations: BMI = body mass index classification; E = endurance training group; G = intervention group; PA = physical activity recommendations group; S = strength training group; SE = combined strength + endurance training group; T = time; VO2peak = peak oxygen consumption; VT1 = aerobic ventilatory threshold; VT2 = anaerobic ventilatory threshold or respiratory compensation point physical activity.
p < 0.05, **p < 0.001, compared with baseline.
p < 0.05, compared with S group.
Fig. 2Time-to-exhaustion delta in minutes. Error bars represent one standard error of the mean. *p < 0.05, **p < 0.001, baseline–post differences; #p < 0.05, compared with PA group in female. E = endurance training group; PA = physical activity recommendation group; S = strength training group; SE = combined strength + endurance training group.